SR15006

CAS No. 2505001-54-5

SR15006( —— )

Catalog No. M28507 CAS No. 2505001-54-5

SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 Get Quote
5MG 50 Get Quote
10MG 87 Get Quote
25MG 178 Get Quote
50MG 335 Get Quote
100MG 500 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SR15006
  • Note
    Research use only, not for human use.
  • Brief Description
    SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).
  • Description
    SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).(In Vitro):In DLD-1 CRC cells, SR15006 (1 μM or 10 μM) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
  • In Vitro
    SR15006 (1 μM or 10 μM; DLD-1 CRC cells) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2505001-54-5
  • Formula Weight
    385.87
  • Molecular Formula
    C16H20ClN3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (259.15 mM)
  • SMILES
    O=C(C=CC=1C=CC=C(Cl)C1)NCC(=O)N2CCN(CC2)S(=O)(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DHX9-IN-2

    DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.

  • HALOFUGINONE LACTATE

    HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM.?Halofuginone is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activityhalofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.?HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity;?this inhibition is reversed by the addition of exogenous proline or EPRS.

  • DTP3 TFA

    DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 (10 μM; 1-21 days) causes the potent and tumor-selective induction of JNK activation and apoptosis.